Benign neoplasm of mediastinum
ICD-10 D15.2 is a billable code used to indicate a diagnosis of benign neoplasm of mediastinum.
Benign neoplasms of the mediastinum are non-cancerous tumors that arise in the mediastinal space, which is located between the lungs and contains vital structures such as the heart, great vessels, trachea, esophagus, and thymus. These neoplasms can be classified into various types, including thymomas, neurogenic tumors, and germ cell tumors. While benign, these tumors can cause significant symptoms due to their location, including respiratory distress, chest pain, or obstruction of nearby structures. Diagnosis typically involves imaging studies such as chest X-rays, CT scans, or MRIs, followed by biopsy for definitive diagnosis. Surveillance is crucial as some benign tumors may exhibit growth or cause complications, necessitating surgical intervention. Although the malignant potential of benign neoplasms is low, certain types, such as thymomas, may have associated risks for malignant transformation. Regular follow-up and monitoring are essential to ensure timely management of any changes in the tumor's behavior.
Detailed pathology reports, imaging studies, and treatment plans.
Management of thymomas and neurogenic tumors, including surgical interventions.
Ensure accurate staging and follow-up documentation to monitor for potential malignant transformation.
Pulmonary function tests, imaging results, and symptom assessments.
Evaluation of mediastinal masses causing respiratory symptoms.
Document the impact of the neoplasm on respiratory function and any interventions performed.
Used when a benign mediastinal tumor is surgically removed.
Operative report detailing the tumor's characteristics and surgical approach.
Ensure alignment between the surgical procedure and the diagnosis of a benign neoplasm.
Common types include thymomas, neurogenic tumors, and germ cell tumors. Each type may have different implications for treatment and follow-up.
